Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 5-Bromouridine

5-Bromouridine

5-Bromouridine structure

5-Bromouridine 

structure
  • CAS No:

    957-75-5

  • Formula:

    C9H11BrN2O6

  • Chemical Name:

    5-Bromouridine

  • Synonyms:

    Uridine,5-bromo-;5-Bromouridine;(-)-5-Bromouridine;NSC 38296;4-Amino-5-bromo-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;21597-77-3;1294478-58-2

  • Categories:

    Biochemical Engineering  >  Nucleoside Drugs

Description

WHITE FINE POWDER


5-Bromouridine (BrUrd) is a uridine derivative with a bromo substituent at the fifth carbon. BrUrd is incorporated into RNA and can be detected immunocytochemically and analysed by cytometry. It causes DNA damage through base substitution and increases the number of mutations.


5-bromouridine is a uridine having a bromo substituent at the 5-position. It has a role as a mutagen.

5-Bromouridine Basic Attributes

323.1

323.10

213-486-6

KEY8PG1BRC

29349990

Characteristics

119

-1.1

white powder

2.0±0.1 g/cm3

181-184 °C (decomp)

1.691

Insoluble in water.

0-6°C

-11 º (c=2 in H2O)

Safety Information

3

22-24/25

YU7300000

Stable under normal temperatures and pressures.

S22-S24/25

Drug Information

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)|Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)|Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

1-D-ribofuranosyl-5-bromouracil-nucleoside

5-Bromouridine Use and Manufacturing

Methods of Manufacturing

General procedure: 2'-O-Methyluridine (5, 0.103 g, 0.4 mmol) was dissolved in aqueous acetonitrile solution(H2O:CH3CN 1:9, 5 mL) under stirring. NaN3 (0.104 g, 1.6 mmol) was added, followed by addition of SMBI (0.101 g, 0.44 mmol) at r.t. and the mixture was stirred. Progress of the reaction was followedby TLC. On completion of the reaction after 1.5 h, the reaction mixture was filtered, evaporated todryness under reduced pressure and coevaporated with acetonitrile (2 × 2 mL). The crude reactionmixture was purified by column chromatography (4percent–6percent MeOH in DCM, v/v) to afford bromonucleoside 6 (0.117 g, 93percent) in pure form as a white solidTypical procedure for the bromination of unprotected nucleosides: DBH (323 mg, 1.13 mmol) was added to a stirred solution of 1d (500 mg, 2.05 mmol) in DMF (5 mL). The resulting pale-yellow solution was stirred at room temperature for 20 minutes or until TLC showed absence of starting material and formation of less polar product. Volatiles were evaporated and the residue was coevaporated with MeCN. The resulting pale solid was crystallized from hot acetone to give 2d (500 mg, 75percent) as colorless crystals with data as reported.To a solution of uridine 146 (20.0 g, 82mmol) and N BS (21 .7 g, 0.12 mol) in anhydrous dimethylfomamide was added AIBN (0.1 eq) in anhydrous dimethylfomamide, then the solution was stirred at 80 °C for 4 h. Saturated sodium thiosulfate solution (20 mL) was added. After evaporation of the solvent, the residue was precipitation with methanol to give 22.0 g compound 147 as light yellow solid.Synthesis of Compound 147: To a solution of uridine 146 (20.0 g, 82mmol) and NBS (21 .7 g, 0.12 mol) in anhydrous dimethylfomamide was added AIBN (0.1 eq) in anhydrous dimethylfomamide, then the solution was stirred at 80 °C for 4 h. Saturated sodium thiosulfate solution (20 mL) was added. After evaporation of the solvent, the residue was precipitation with methanol to give 22.0 g compound 147 as light yellow solid.Synthesis of Compound 1 47: To a solution of uridine 146 (20.0 g, 82mmol) and NBS (21 .7 g, 2 mol) in anhydrous dimethylfomamide was added AIBN (0.1 eq) in anhydrous dimethylfomamide, n the solution was stirred at 80 °C for 4 h. Saturated sodium thiosulfate solution (20 mL) was ded. Afte ompound 1Synthesis of Compound 147: To a solution of uridine 146 (20.0 g, 82mmol) and NBS (21.7 g, 0.12 mol) in anhydrous dimethylfomamide was added AIBN (0.1 eq) in anhydrous dimethylfomamide, then the solution was stirred at 80 °C for 4 h. Saturated sodium thiosulfate solution (20 mL) was added. After evaporation of the solvent, the residue was precipitation with methanol to give 22.0 g compound 147 as light yellow solid.

Uses

5-Bromouridine is a uridine (U829910) derivative and is often incorporated into RNA in order to detect immunocytochemically and analyzed by cytometry.

Computed Properties

Molecular Weight:323.10
XLogP3:-1.1
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:2
Exact Mass:321.98005
Monoisotopic Mass:321.98005
Topological Polar Surface Area:119
Heavy Atom Count:18
Complexity:414
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 5-Bromouridine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.